Armstrong, A J <br/><br/>
Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer.  [electronic resource] 

 -  Prostate cancer and prostatic diseases  Jun 2010 
 - 108-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1476-5608 
<br/><br/><label>Standard No.: </label>10.1038/pcan.2009.62  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials as Topic<br/>Docetaxel<br/>Drug Administration Schedule<br/>Humans<br/>Male<br/>Neoplasm Metastasis--prevention & control<br/>Orchiectomy<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Prostatic Neoplasms--drug therapy<br/>Substance Withdrawal Syndrome<br/>Taxoids--administration & dosage<br/>Treatment Outcome